Experiment 428231
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | PAZDUR,R: NEWMAN,RA: NEWMAN,BM: FUENTES,A: BENVENUTO,J: BREADY,B: MOORE JR,D: JAIYESIMI,I: VREELAND,F: BAYSSAS,MMG: RABER,MN:. (1992). PHASE I TRIAL OF TAXOTERE: FIVE-DAY SCHEDULE.. 84(23) |
| Amount utilized | |
| Compound isolated | |
| Disease | 39 CANCER PATIENTS WITH ADVANCED DISEASE WERE ENTERED IN THIS PHASE 1 STUDY. PATIENTS WERE GIVEN DOSE DAILY FOR 5 CONSECUTIVE DAYS WITH COURSES BEING REPEATED EVERY 21 DAYS FOR A MAXIMUM OF 31 COURSES. OTHER TOXICITIES INCLUDED NAUSEA, VOMITING, DIARRHEA AND THROMBOCYTOPENIA. 6 OVARIAN CANCER PATIENTS EXPERIENCED EVIDENCE OF CLINICAL ANTITUMOR RESPONSE. ONE OF THESE PATIENTS ATTAINED COMPLETE RESPONSE. A PATIENT WITH ADVANCED BREAST CARCINOMA ATTAINED A PARTIAL RESPONSE. |
| Dose amount | 1.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |